Endo International plc – Ordinary Shares (ENDP) was Reiterated by Stifel to “Buy” while Lowering the Price Target of the company shares to $ 25 from a previous price target of $75 . Stifel advised their investors in a research report released on May 18, 2016.
Many Wall Street Analysts have commented on Endo International plc – Ordinary Shares. Shares were Reiterated by Deutsche Bank on May 9, 2016 to “Buy” and Lowered the Price Target to $ 31 from a previous price target of $61 .Shares were Reiterated by Stifel on May 6, 2016 to “Buy” and Lowered the Price Target to $ 75 from a previous price target of $90 .Shares were Reiterated by Barclays on May 6, 2016 to “Equal Weight” and Lowered the Price Target to $ 28 from a previous price target of $37 .
On the company’s financial health, Endo International plc – Ordinary Shares reported $1.08 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on May 5, 2016. Analyst had a consensus of $1.04. The company had revenue of $963.54 million for the quarter, compared to analysts expectations of $956.08 million. The company’s revenue was up 34.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.17 EPS.
Endo International plc – Ordinary Shares opened for trading at $14.05 and hit $14.45 on the upside on Monday, eventually ending the session at $14.3, with a gain of 1.78% or 0.25 points. The heightened volatility saw the trading volume jump to 94,15,814 shares. Company has a market cap of $3,184 M.
In a different news, on May 12, 2016, Arthur J Higgins (director) purchased 5,000 shares at $13.80 per share price. According to the SEC, on May 11, 2016, Roger H Kimmel (director) purchased 7,000 shares at $15.57 per share price. On May 11, 2016, Paul Campanelli (Group President, Generics) purchased 13,000 shares at $15.53 per share price, according to the Form-4 filing with the securities and exchange commission.